Shares of Gilead Sciences Inc. fell in after-hours trading Thursday after a World Health Organization panel recommended against doctors using the drug remdesivir to treat coronavirus patients.

from MarketWatch.com - Top Stories https://ift.tt/3kMNCkn
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3kMNCkn
via IFTTT
Kommentare
Kommentar veröffentlichen